|
antibacterial |
2 |
|
antifouling |
2 |
|
archaeal secondary metabolites |
2 |
|
bacteriocins |
2 |
|
biofilms |
2 |
|
biofouling |
2 |
|
biosynthetic gene clusters |
2 |
|
chemical biology |
2 |
|
elasnin |
2 |
|
genome mining |
2 |
|
gut microbiota |
2 |
|
human microbiome |
2 |
|
lactic acid bacteria |
2 |
|
lanthipeptide |
2 |
|
marine natural products |
2 |
|
natural products |
2 |
|
ribosomally synthesized and post-translationally modified peptides |
2 |
|
ripp |
2 |
|
ripps |
2 |
|
secondary metabolites |
2 |
|
vaginal microbiome |
2 |
|
agallochaols k-q |
1 |
|
amphipod |
1 |
|
anti-fouling activity |
1 |
|
anti-inflammatory activity |
1 |
|
anti-larval settlement |
1 |
|
antibiofilm |
1 |
|
antibiotic |
1 |
|
antifouling compounds |
1 |
|
antilarval settlement |
1 |
|
antimicrobial activity |
1 |
|
antimicrobials |
1 |
|
antimycin b |
1 |
|
assays |
1 |
|
bacillus subtilis |
1 |
|
balanus (=amphibalanus) amphitrite |
1 |
|
balanus amphitrite |
1 |
|
barnacle |
1 |
|
biological activity |
1 |
|
biosynthetic enzymes |
1 |
|
biosynthetic gene cluster |
1 |
|
brood pouch |
1 |
|
butenolides |
1 |
|
cembrane-type diterpenoid |
1 |
|
citreamicin |
1 |
|
colibactin |
1 |
|
colistin |
1 |
|
cytochrome p450 enzymes |
1 |
|
cytotoxicity |
1 |
|
diindol-3-ylmethane |
1 |
|
eradication |
1 |
|
escherichia coli |
1 |
|
euphorbiaceae |
1 |
|
excoecaria agallocha l. |
1 |
|
excoecariphenols a-d |
1 |
|
experimental autoimmune encephalomyelitis |
1 |
|
hadal trench |
1 |
|
hcv rna inhibition |
1 |
|
heterologous expression |
1 |
|
huh 7.5 cells |
1 |
|
hydrolysis |
1 |
|
integrative omics |
1 |
|
lipids |
1 |
|
lipoamicoumacin |
1 |
|
lipopeptide |
1 |
|
lipophilicity |
1 |
|
low-toxicity antifouling compounds |
1 |
|
macrocyclization |
1 |
|
male pregnancy |
1 |
|
mangrove plant |
1 |
|
mariana trench |
1 |
|
marine |
1 |
|
marine soft coral |
1 |
|
marine-derived actinomycete |
1 |
|
marine-derived fungus |
1 |
|
metabolic engineering |
1 |
|
metagenome mining |
1 |
|
metagenomics |
1 |
|
molecular mimicry |
1 |
|
mrsa |
1 |
|
multiple sclerosis |
1 |
|
ns3-4a protein kinase inhibition |
1 |
|
paenibacillus polymyxa |
1 |
|
peptide macrocyclization |
1 |
|
peptides and proteins |
1 |
|
precolibactin |
1 |
|
prodrug mechanism |
1 |
|
pseudovibrio |
1 |
|
psychromonas |
1 |
|
resistance |
1 |
|
retinoic acid |
1 |
|
ripp biosynthesis |
1 |
|
seahorse |
1 |
|
side chain modification |
1 |
|
side chains |
1 |
|
sinularia rigida |
1 |
|
sinulariols a-s |
1 |
|
speco |
1 |
|
streptomyces caelestis |
1 |
|
streptomyces lusitanus |
1 |
|
structural diversity |
1 |
|
structural elucidation |
1 |
|
structural optimization |
1 |
|
structure elucidation |
1 |
|
structure-activity relationship |
1 |
|
thielavia sp. |
1 |
|
thielavins |
1 |
